Evidence map›Paper›PMID 31644588›Full record

ArticlePloS one2019

Supporting informed clinical trial decisions: Results from a randomized controlled trial evaluating a digital decision support tool for those with intellectual disability.

Lauren A McCormack, Amanda Wylie, Rebecca Moultrie, Robert D Furberg, Anne C Wheeler, Katherine Treiman, Donald B Bailey, Melissa Raspa

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lauren A McCormackPublic Health Research Division, RTI International, Research Triangle Park, North Carolina, United States of America.ORCID 0000-0002-5362-0540
Amanda WylieCenter for Newborn Screening, RTI International, Research Triangle Park, North Carolina, United States of America.
Rebecca MoultriePublic Health Research Division, RTI International, Research Triangle Park, North Carolina, United States of America.
Robert D FurbergHealth Quality & Analytics, RTI International, Research Triangle Park, North Carolina, United States of America.
Anne C WheelerCenter for Newborn Screening, RTI International, Research Triangle Park, North Carolina, United States of America.
Katherine TreimanPublic Health Research Division, RTI International, Research Triangle Park, North Carolina, United States of America.
Donald B BaileyCenter for Newborn Screening, RTI International, Research Triangle Park, North Carolina, United States of America.
Melissa RaspaCenter for Newborn Screening, RTI International, Research Triangle Park, North Carolina, United States of America.ORCID 0000-0003-3791-3367

Funding

Decisional Capacity and Informed Consent in Fragile X SyndromeR01HD071987 · NICHD · RESEARCH TRIANGLE INSTITUTE · PI BAILEY, DONALD B · 2012 to 2016
$3.1M
NICHD NIH HHS R01 HD071987
6 · The paper itself

Abstract

backgroundInformed consent requires that individuals understand the nature of the study, risks and benefits of participation. Individuals with intellectual disabilities (ID) have cognitive and adaptive impairments that may affect their ability to provide informed consent. New treatments and clinical trials for fragile X syndrome, the most commonly known inherited cause of ID, necessitate the development of methods to improve the informed consent process. The goal of this study was to compare the efficacy of a digital decision support tool with that of standard practice for informed consent and to examine whether the tool can improve decisional capacity for higher functioning individuals.

methodsParticipants (N = 89; mean age = 21.2 years) were allocated to the experimental group (consenting information provided via the digital decision support tool), or the comparison group (information provided via standard practice). Participants were assessed on four aspects of decisional capacity (Understanding, Appreciating, Reasoning, and Expressing a choice). We used regression analyses to test the impact of the tool on each outcome, repeating the analyses on the higher functioning subsample.

resultsNo differences existed in any domain of decisional capacity for the sample in full. However, participants in the higher IQ subsample who used the tool scored better on Understanding after adjustment (β = 0.25, p = 0.04), but not on Appreciating or Reasoning. No differences by experimental group existed in the decision to join the hypothetical trial for the full sample or higher functioning subsample.

conclusionsA decision support tool shows promise for individuals with fragile X syndrome with higher cognitive abilities. Future studies should examine the level of cognitive ability needed for sufficient understanding, whether these findings can be translated to other clinical populations, and the impact of the tool in larger trials and on trial retention.

Indexed as

Decision MakingDecision Support Systems, ClinicalInformed ConsentPatient SelectionAdolescentAdultChildFemaleHealth Knowledge, Attitudes, PracticeHumansIntellectual DisabilityMalePatient ParticipationRandomized Controlled Trials as TopicResearch SubjectsSurveys and Questionnaires

Identifiers

PMID31644588
PMCPMC6808417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.